JP2024520020A5 - - Google Patents
Info
- Publication number
- JP2024520020A5 JP2024520020A5 JP2023572876A JP2023572876A JP2024520020A5 JP 2024520020 A5 JP2024520020 A5 JP 2024520020A5 JP 2023572876 A JP2023572876 A JP 2023572876A JP 2023572876 A JP2023572876 A JP 2023572876A JP 2024520020 A5 JP2024520020 A5 JP 2024520020A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- score
- nash
- nash crn
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163194088P | 2021-05-27 | 2021-05-27 | |
| US63/194,088 | 2021-05-27 | ||
| PCT/IB2022/054867 WO2022249071A1 (en) | 2021-05-27 | 2022-05-25 | Pemafibrate and/or tofogliflozin for use in treating liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520020A JP2024520020A (ja) | 2024-05-21 |
| JP2024520020A5 true JP2024520020A5 (enExample) | 2025-05-08 |
Family
ID=82020168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572876A Pending JP2024520020A (ja) | 2021-05-27 | 2022-05-25 | 肝疾患の治療における使用のためのペマフィブラートおよび／またはトホグリフロジン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240277745A1 (enExample) |
| EP (1) | EP4346809A1 (enExample) |
| JP (1) | JP2024520020A (enExample) |
| KR (1) | KR20240013203A (enExample) |
| CN (1) | CN117677385A (enExample) |
| AU (1) | AU2022282651A1 (enExample) |
| BR (1) | BR112023024701A2 (enExample) |
| CA (1) | CA3221073A1 (enExample) |
| MX (1) | MX2023013886A (enExample) |
| WO (1) | WO2022249071A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250034041A (ko) * | 2022-07-15 | 2025-03-10 | 교와 가부시키가이샤 | 혈중 ldl 콜레스테롤 저하제 |
| CN115991682A (zh) * | 2023-03-21 | 2023-04-21 | 广州佳途科技股份有限公司 | 一种培马贝特-d4的制备方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI696462B (zh) | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
| ES3026786T3 (en) | 2017-01-11 | 2025-06-12 | Kowa Co | Pemafibrate in combination with a sglt2 inhibitor for the prophylactic or therapeutic treatment of liver diseases nonalcoholic fatty liver disease |
-
2022
- 2022-05-25 BR BR112023024701A patent/BR112023024701A2/pt unknown
- 2022-05-25 JP JP2023572876A patent/JP2024520020A/ja active Pending
- 2022-05-25 US US18/564,115 patent/US20240277745A1/en active Pending
- 2022-05-25 WO PCT/IB2022/054867 patent/WO2022249071A1/en not_active Ceased
- 2022-05-25 CN CN202280050095.0A patent/CN117677385A/zh active Pending
- 2022-05-25 MX MX2023013886A patent/MX2023013886A/es unknown
- 2022-05-25 EP EP22729797.5A patent/EP4346809A1/en active Pending
- 2022-05-25 KR KR1020237044685A patent/KR20240013203A/ko active Pending
- 2022-05-25 AU AU2022282651A patent/AU2022282651A1/en active Pending
- 2022-05-25 CA CA3221073A patent/CA3221073A1/en active Pending